complex CRGN) and no immune deposits (pauci-immune CRGN) (1). Goodpasture's syndrome is characterized by CRGN and alveolar hemorrhage with linear deposi tion of IgG along the glomerular and alveolar basement membranes. It is generally accepted that CRGN in Goodpasture's syndrome is mediated by circulating anti-glomerular basement membrane (GBM) antibodies (2-3). Anti-neutrophil cytoplasmic antibodies (ANCA) have recently been detected in patients with pauci immune CRGN, such as idiopathic . ANCA are divided into two subsets, perinuclear pattern ANCA (p-ANCA) and diffuse cytoplasmic pattern ANCA (c-ANCA), by indirect immunofluorescence of alcohol-fixed human neutrophils. It is known that one p-ANCA is the antibody to myeloperoxidase (MPO) in the neutrophil cytoplasm (5). It has been reported that ANCA, especially anti-MPO antibodies, might play an important role in the pathogenesis of pauci-immune CRGN (5-7). In this paper, we report a case of Goodpasture's syndrome associated with anti-MPO antibodies. To our knowledge, there have been only a few previous reports of Goodpasture's syndrome with anti-MPO antibodies (9-12). The present case suggested that not only anti GBM antibodies, but also anti-MPO antibodies may participate in the pathogenesis of CRGN in Good pasture's syndrome, especially with vasculitis. Methods Anti-GBM antibodies were detected by radioim munoassay utilizing radiolabeled human GBM antigens isolated from the noncollagenous glycoproteins of the GBM remaining after collagenase digestion. p-ANCA and c-ANCA were detected by indirect immunofluo rescence assay (IIF). The method of van der Woude et al (13) was used for IIF. Anti-MPO antibodies were detected by enzyme-linked immunosorbent assay (ELISA) (normal range, <10 ELISA unit/ml) using microplates (BioCarb Diagnostics, Lund, Sweden) coated with were detected by using microplate (BioCarb Diagnostics) coated with 29 kd serin protease isolatd from alfa gran ules of human granulocytes.
Patient
A 61-year-old male was admitted to a local hospital because of exertional dyspnea on January 12, 1984. He was a smoker (40 cigarettes per day) for 30yr, had a history of pulmonary tuberculosis at the age of 31 and had repeated episodes of upper and lower respiratory tract infection. He had no history of Raynaud's phenom enon, hair loss, facial erythema or polyarthralgia suggest ing collagen disease. On admission, the chest X-ray disclosed pulmonary fibrosis and bilateral pleural thickening. Laboratory examination revealed a normal urinalysis and normal BUN and serum creatinine (S-Cr) levels. Hemoptysis, proteinuria and increased BUN and S-Cr were first noted in April 1984. He was transferred to our hospital because of progressively worsening renal failure and respiratory failure on July 16, 1984. On admission, he was 164cm in height and weighed 46.5kg. Facial and extremity edema was present. His blood pressure was 120/80 mmHg, and his pulse rate was 106/min and regular. On ausculation, coarse crackles Table 1 . Laboratory Data on Admission were audible in the right lung and the second pulmon ary heart sound was accentuated. Laboratory findings are shown in Table 1 . Urinary protein was 155mg/dl, urinary sugar was negative and urinary sediment had numerous dysmorphic blood cells and 1 to 2 granular casts/HPF. Laboratory data included BUN 117mg/dl, S-Cr 14.4mg/dl, and potassium 6.5meq/l. WBC was 9,900/mm3, hematocrit 26.9% , and c-reactire protein 4+, C3 was 50mg/dl, and C4 and CH50 levels were within normal range. Circulating immune complexes were not present but anti-GBM antibodies were positive. P-ANCA were detected by IIF and anti-MPO antibodies were detected at 60 ELISA unit/ml. Anti-nuclear anti bodies were positive (1: 160) in a speckled pattern. Anti-DNA antibodies, anti-RNP antibodies, anti-SM antibodies and rheumatoid factors were not detected. Blood, sputum and urine cultures were negative. A chest X-ray showed a reticular shadow in the right midzone, pulmonary fibrosis and pleural thickening as shown in Fig. 1 . From these clinical and laboratory findings, a diagnosis of rapidly progressive glomerulonephritis with pul monary hemorrhage was made. As shown in Fig. 2 , the patient was started on prednisolone (60mg/day) and hemodialysis. He died of respiratory failure 3 months after admission. Autopsy revealed CRGN and alveolar hemorrhage (14) and Savage et al (15) reported that idiopathic CRGN is related to the spectrum of vascu litis known as microscopic polyarteritis, since systemic vasculitis might begin as kidney limited polyarteritis, and they suggested that there is a common pathogenesis between systemic vasculitis and idiopathic CRGN. Falk and Jennette (5) reported that ANCA, especially anti-MPO antibodies, are related to idiopathic CRGN as renal-limited polyarteritis, rather than extra-renal systemic vasculitis, and that C-ANCA are related to lung and sinus involvement. It is reported that the sensitivity and specificity of anti-MPO antibodies for idiopathic CRGN are 75% and 92%, respectively (6). We (7) reported ll cases with anti-MPO antibodies, 7 cases were CRGN and 4 cases were glomerulonephritis with a moderate degree of crescent formation. Six of the 7 CRGN cases with anti-MPO antibodies were pauci-immune CRGN. Furthermore, 3 of the 6 cases of pauci-immune CRGN were associated with pulmonary hemorrhage. Therefore, it is suggested that ANCA, especially anti-MPO antibodies, may play an important pathogenic role in pauci-immune CRGN as renal vas culitis and probably pulmonary hemorrhage. In the present case, anti-MPO antibodies were de tected, but C-ANCA were negative. Also, systemic vasculitis was not found at autopsy. ANCA have been detected in only a few patients without vasculitis or CRGN, including atrial myxoma, pneumonia, leptospirosis, active tuberculosis and collagen diseases (16) (17) (18) . These infectious and collagen diseases were not found on clinical or pathological examination in the present case. These findings suggest that anti-MPO antibodies may have played a role in the pathogenesis of CRGN as renal vasculitis in the present patient with Goodpasture's syndrome. Although there have been few reports of patients with both ANCA and anti-GBM antibodies, Pusey and Lockwood (9) reported 20 patients with both antibodies in 890 patients with rapidly progressive glomeru lonephritis and Jayne et al (10) (2) and Kondo et al (3) all reported Goodpasture's syndrome associated with systemic vasculitis. Anti-nuclear antibodies were detected in the present patient, but collagen diseases and other diseases usually associated with anti-nuclear antibodies were not found on clinical and pathological examination. Although the function of cellular immunity and genetic factors was not examined, an immunological disorder producing auto antibodies, such as anti-nuclear antibodies and anti MPO antibodies, might have been present in this case.
Although the pathogenic role of anti-MPO antibodies in CRGN remains unknown, Falk et al (21) reported that anti-MPO antibodies activate neutrophils and induce oxygen radical release and primary granule degranulation. It is reported that MPO exists in the primary granule as a neutrophil cationic enzyme which reacts with glomerular polyanion on the glomerular capillary wall, and MPO causes glomerular injury by reacting with H2O2, which is one of the reactive oxygen species derived from activated neutrophils (22, 23) . MPO on the glomerular capillary wall might be related to basement membrane damage resulting in the rupture of the GBM via neutrophil acti vation by anti-MPO antibodies. The mechanism of the simultaneous presence of both anti-MPO antibodies and anti-GBM antibodies is not known. Since cross reactivity of these autoantibodies is not found, there may be some common immunological disorder of cellular immunity producing these autoantibodies.
It was concluded that not only anti-GBM antibodies but also anti-MPO antibodies might participate in the pathogenesis of CRGN and probably alveolar hemorrhage in Goodpasture's syndrome, especially that associated with vasculitis. 
